(VIANEWS) – Century Communities (CCS), International General Insurance Holdings Ltd. (IGIC), Boston Scientific (BSX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Century Communities (CCS)
14.9% sales growth and 11.43% return on equity
Century Communities, Inc., together with its subsidiaries, engages in the design, development, construction, marketing, and sale of single-family attached and detached homes. It is also involved in the entitlement and development of the underlying land; and provision of mortgage, title, and insurance services to its home buyers. The company offers homes under the Century Communities and Century Complete brands. It sells homes through its sales representatives, as well as through independent real estate brokers in 17 states in the United States. Century Communities, Inc. was founded in 2002 and is headquartered in Greenwood Village, Colorado.
Earnings Per Share
As for profitability, Century Communities has a trailing twelve months EPS of $8.05.
PE Ratio
Century Communities has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing $10.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.43%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 3.69B for the twelve trailing months.
2. International General Insurance Holdings Ltd. (IGIC)
10% sales growth and 23.87% return on equity
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Earnings Per Share
As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $2.17.
PE Ratio
International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 5.82. Meaning, the purchaser of the share is investing $5.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.87%.
Volume
Today’s last reported volume for International General Insurance Holdings Ltd. is 64633 which is 22.81% above its average volume of 52625.
Sales Growth
International General Insurance Holdings Ltd.’s sales growth is 10% for the present quarter and 10% for the next.
3. Boston Scientific (BSX)
9.1% sales growth and 8.58% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $1.07.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 62.5. Meaning, the purchaser of the share is investing $62.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.58%.
Sales Growth
Boston Scientific’s sales growth is 8.7% for the present quarter and 9.1% for the next.
Volume
Today’s last reported volume for Boston Scientific is 1221030 which is 81.65% below its average volume of 6654890.
4. Gentex Corporation (GNTX)
8.8% sales growth and 19.57% return on equity
Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, and internationally. It operates through Automotive Products and Other segments. The company offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and non-automatic-dimming rearview mirrors for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers. It also provides variable dimmable windows to aircraft manufacturers and airline operators. In addition, the company offers photoelectric smoke detectors and alarms, electrochemical carbon monoxide alarms and detectors, audible and visual signaling alarms, and bells and speakers used in fire detection systems in office buildings, hotels, and other commercial and residential buildings, as well as researches and develops nanofiber chemical sensing products. The company sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. Gentex Corporation was incorporated in 1974 and is headquartered in Zeeland, Michigan.
Earnings Per Share
As for profitability, Gentex Corporation has a trailing twelve months EPS of $1.84.
PE Ratio
Gentex Corporation has a trailing twelve months price to earnings ratio of 20.16. Meaning, the purchaser of the share is investing $20.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.57%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 4, 2024, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 1.29%.
Sales Growth
Gentex Corporation’s sales growth is 9.1% for the present quarter and 8.8% for the next.
Volume
Today’s last reported volume for Gentex Corporation is 1232980 which is 11.33% below its average volume of 1390670.
